Effect of opioid active therapeutics on the ascending reflex pathway in the rat ileum

H D Allescher1, M Storr, C Piller

  • 1Department of Internal Medicine II, Technical University of Munich, Ismaningerstr. 22, 81675 Munich, Germany. hans.allescher@lrz.tu-muenchen.de

Neuropeptides
|October 7, 2000
PubMed

Insights

Opioid receptor agonists like loperamide inhibit antidiarrheal reflexes by affecting myenteric reflexes. Casomorphins may offer localized gut therapy without systemic absorption, suggesting new therapeutic applications.

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Neuroscience

Background:

  • Opioid receptor agonists are established antidiarrheal agents.
  • Their effects on gut motility are known, but impact on myenteric reflexes and luminal action is unclear.

Purpose of the Study:

  • Investigate the effects of opioid-active substances on myenteric reflexes in the isolated rat ileum.
  • Compare luminal versus serosal application of these agents.

Main Methods:

  • Studied ascending contractile reflex pathway in isolated rat ileum.
  • Utilized opioid agonists (loperamide, fedotozine, beta-casomorphin-4, beta-CM-4027) and naloxone.
  • Compared luminal and serosal drug application.

Main Results:

  • Opioid agonists inhibited reflex response efficacy and increased reflex latency, effects blocked by naloxone.
  • beta-CM-4027 showed the most potent inhibition (IC50: 1.4x10(-7)M).
  • Beta-casomorphin-4 demonstrated a localized effect, requiring 750x higher concentration luminally than serosally.

Conclusions:

  • Opioid drugs modulate peristaltic reflexes by altering efficacy and timing via opioid receptors.
  • Casomorphins may exert local effects on the gut wall, suggesting potential for targeted antidiarrheal therapies.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...